{"id":5089,"date":"2019-12-23T15:53:33","date_gmt":"2019-12-23T06:53:33","guid":{"rendered":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/contents\/?p=5089"},"modified":"2019-12-23T15:53:33","modified_gmt":"2019-12-23T06:53:33","slug":"2018%e5%b9%b4%e6%a5%ad%e7%b8%be%e3%80%80%e3%81%9d%e3%81%ae2","status":"publish","type":"post","link":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/%e7%a0%94%e7%a9%b6%e7%b4%b9%e4%bb%8b\/5089\/","title":{"rendered":"2018\u5e74\u696d\u7e3e\u3000\u305d\u306e2"},"content":{"rendered":"<p>2018\u5e74\u696d\u7e3e\u3000\u305d\u306e2<br \/>\n\u25a0\u3000\u5b66\u4f1a\u30fb\u7814\u7a76\u4f1a\u767a\u8868<br \/>\n<a href=\"http:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wordpress\/?p=5089#06\">\u56fd\u5185\u5b66\u4f1a\uff08\u5168\u56fd\uff09<\/a><br \/>\n<a href=\"http:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wordpress\/?p=5089#07\">\u56fd\u5185\u5b66\u4f1a\uff08\u5730\u65b9\u4f1a\uff09<\/a><br \/>\n\u25a0 <a href=\"http:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wordpress\/?p=5089#08\">\u8b1b\u6f14<\/a><br \/>\n\u25a0 <a href=\"http:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wordpress\/?p=5089#09\">\u7814\u7a76\u52a9\u6210<\/a><br \/>\n\u25a0 <a href=\"http:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wordpress\/?p=5089#10\">\u53d7\u8cde<\/a><br \/>\n\u8ad6\u6587\u3001\u56fd\u969b\u5b66\u4f1a\u767a\u8868\u306f<a href=\"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wordpress\/?p=5085&amp;preview=true\">2018\u5e74\u696d\u7e3e\u3000\u305d\u306e1<\/a>\u3092\u3054\u89a7\u4e0b\u3055\u3044\u3002<br \/>\n&nbsp;<br \/>\n<strong><span style=\"color: #336699;\">\u25a0<\/span> \u5b66\u4f1a\u767a\u8868(\u56fd\u5185)<\/strong><br \/>\n<a name=\"06\"><\/a><span style=\"color: #d391a8;\">\u25cf<\/span> \u56fd\u5185\u5b66\u4f1a(\u5168\u56fd)<br \/>\n1. \u5009\u7530\u8056\uff0c\u5ddd\u6761\u6587\u9686\uff0c\u6c60\u6c34\u6681\u5f66\uff0c\u7530\u4e2d\u6587\u884c\uff0c\u4f0a\u7530\u52dd\u5178\uff0c\u6771\u91ce\u535a\uff0c\u963f\u90e8\u5145\u4f2f\uff0c\u5e73\u4e95\u90a6\u660e\uff0c\u6a2a\u4e95\u5b5d\u5f18\uff0c\u5ddd\u53e3\u76f4\u4eba\uff0c\u57ce\u6238\u8f1d\u4ec1\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u671b\u6708\u8f1d\u4e00\uff0e\u5fc3\u8840\u7ba1CT\u524d\u306e\u751f\u7406\u98df\u5869\u6c34\u30c6\u30b9\u30c8\uff1a\u3000\u9020\u5f71\u5264\u306e\u8840\u7ba1\u5916\u6f0f\u51fa\u306e\u4e88\u9632\u3068\u3057\u3066\uff0e\u7b2c 28 \u56de \u65e5\u672c\u5fc3\u8840\u7ba1\u753b\u50cf\u52d5\u614b\u5b66\u4f1a(2018\uff0c1\uff0c\u6771\u4eac)<br \/>\n2. \u6a2a\u4e95\u656c\u5f18, \u57ce\u6238\u8f1d\u4ec1, \u6851\u539f\u5948\u90fd\u7f8e, \u5e73\u4e95\u90a6\u660e, \u5ddd\u53e3\u76f4\u4eba, \u5009\u7530\u8056, \u4e2d\u6751\u58ee\u5fd7, \u57ce\u6238\u502b\u4e4b, \u671b\u6708\u8f1d\u4e00. \u8ca0\u8377\u30c0\u30a4\u30ca\u30df\u30c3\u30af\u5fc3\u7b4bCT perfusion\u691c\u67fb\u306b\u304a\u3051\u308brelative CT-MBF\u306e\u5fc3\u7b4b\u865a\u8840\u8a3a\u65ad\u80fd\u8a55\u4fa1\u306b\u95a2\u3059\u308b\u691c\u8a0e. \u7b2c86\u56de\u65e5\u672c\u5fc3\u81d3\u653e\u5c04\u7dda\u7814\u7a76\u4f1a (2018. 1, \u6771\u4eac)<br \/>\n3. \u5c0f\u5ddd\u907c, \u57ce\u6238\u502b\u4e4b, \u4e2d\u6751\u58ee\u5fd7, \u6851\u539f\u5948\u90fd\u7f8e, \u5e73\u4e95\u90a6\u660e, \u6e21\u90e8\u7b11\u9e97, \u6a2a\u4e95\u656c\u5f18, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u5bae\u5ddd\u6b63\u7537, \u671b\u6708\u8f1d\u4e00. Fallot\u56db\u5fb4\u75c7\u5fc3\u5185\u4fee\u5fa9\u8853\u5f8c\u9060\u9694\u671f\u306b\u304a\u3051\u308b\u80ba\u8840\u6d41,\u5fc3\u6a5f\u80fd\u8a55\u4fa1 \u7b2c28\u56de\u65e5\u672c\u5fc3\u8840\u7ba1\u753b\u50cf\u52d5\u614b\u5b66\u4f1a(2018.1,\u6771\u4eac)<br \/>\n4. \u6e21\u90e8\u7b11\u9e97\uff0c\u5bae\u5ddd\u6b63\u7537, \u77f3\u6751\u96bc\u4eba, \u5e73\u4e95\u90a6\u660e, \u6a2a\u4e95\u656c\u5f18, \u5c0f\u5ddd\u907c, \u4e2d\u6751\u58ee\u5fd7, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u671b\u6708\u8f1d\u4e00\uff0e\u5fc3\u623f\u7d30\u52d5\u60a3\u8005\u306b\u304a\u3051\u308bF-18 FDG\u5fc3\u96c6\u7a4d\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e\uff0e\u7b2c28\u56de\u65e5\u672c\u5fc3\u8840\u7ba1\u753b\u50cf\u52d5\u614b\u5b66\u4f1a(2018\uff0e1\uff0c\u6771\u4eac)<br \/>\n5. \u5c0f\u5ddd\u907c, \u4e2d\u6751\u58ee\u5fd7, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1, \u671b\u6708\u8f1d\u4e00. Machine learning\u3092\u4f7f\u7528\u3057\u305f\u80ce\u5150\u306e\u80ba\u6210\u719f\u5ea6\u8a55\u4fa1 \u7b2c10\u56de\u547c\u5438\u6a5f\u80fd\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u7814\u7a76\u4f1a\u5b66\u8853\u96c6\u4f1a(2018.2,\u5927\u962a)<br \/>\n6. \u7530\u4e2d\u5b8f\u660e,\u5ddd\u53e3\u76f4\u4eba,\u6d25\u7530\u5b5d\u6cbb,\u671b\u6708\u8f1d\u4e00,\u798f\u5c71\u76f4\u7d00. \u5c3f\u7ba1\u52d5\u8108\u763b\u306b\u5bfe\u3059\u308b\u30b9\u30c6\u30f3\u30c8\u30b0\u30e9\u30d5\u30c8\u7559\u7f6e\u8853\u306e\u6cbb\u7642\u6210\u7e3e. \u7b2c54\u56de\u65e5\u672c\u8179\u90e8\u6551\u6025\u533b\u5b66\u4f1a\u7dcf\u4f1a (2018.3.\u6771\u4eac)<br \/>\n7. \u6e21\u90e8\u7b11\u9e97, \u5bae\u5ddd\u6b63\u7537, \u77f3\u6751\u96bc\u4eba\uff0c\u5e73\u4e95\u90a6\u660e, \u6a2a\u4e95\u656c\u5f18, \u5c0f\u5ddd\u907c, \u7530\u908a\u88d5\u8cb4, \u4e2d\u6751\u58ee\u5fd7, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u671b\u6708\u8f1d\u4e00\uff0e\u5fc3\u81d3\u5c02\u7528\u534a\u5c0e\u4f53SPECT\u88c5\u7f6e:DNM530c\u3092\u7528\u3044\u305f\u5fc3\u7b4b\u8840\u6d41\u4e88\u5099\u80fd\u306e\u6e2c\u5b9a\uff0eFunctional RevascularIzation ENcouraged by optimal Diagnostic Strategy Live (FRIENDS Live) 2018(2018\uff0e3\uff0c\u6771\u4eac)<br \/>\n8. \u6e21\u90e8\u7b11\u9e97\uff0c\u5bae\u5ddd\u6b63\u7537, \u77f3\u6751\u96bc\u4eba, \u5e73\u4e95\u90a6\u660e, \u6a2a\u4e95\u656c\u5f18, \u5c0f\u5ddd\u907c,\u4e2d\u6751\u58ee\u5fd7, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u671b\u6708\u8f1d\u4e00\uff0e\u5fc3\u623f\u7d30\u52d5\u60a3\u8005\u306b\u304a\u3051\u308bF-18 FDG\u5fc3\u96c6\u7a4d\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e\uff0e\u7b2c77\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a(2018\uff0e3\uff0c\u6a2a\u6d5c)<br \/>\n9. T Tsuda, M Matsuda, Y Sugawara, K Matsuda, K Kikuchi, H Tanaka, T Mochizuki. Imaging of Pediatric and Adult Patients with Anomalous Pancreaticobiliary Ductal Junction. \u7b2c77\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\u3000\u6559\u80b2\u5c55\u793a(2018.4,\u3000\u6771\u4eac)<br \/>\n10. Kuwahara N, Kido T, Yokoi T, Tanabe Y, Nishiyama H, Uetani T, Hirai K, Kawaguchi N, Miyagawa M, Mochizuki T. Comparison of QPR derived from dynamic CT perfusion and FFR on the evaluation of myocardial ischemia. \u7b2c77\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a (2018. 4, \u6a2a\u6d5c)<br \/>\n11. Hiromitsu Kanzaki, Masaaki Kataoka, Kotaro Uwatsu. Treatment Outcomes of Radiotherapy for Lymph Node Recurrence after Radical Surgery for Esophageal Cancer. \u7b2c77\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a(2018.4, \u6a2a\u6d5c)<br \/>\n12. Makita K, Hamamoto Y, Ishikawa H, Takata N, Tsuruoka S, Nagasaki K, Mochizuki T. Influence of CTV displacement in postoperative breast\/chest wall radiotherapy using field in field technique. \u7b2c77\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a (2018. 4, \u6a2a\u6d5c)<br \/>\n13. \u9ad8\u7530\u7d00\u5b50, \u6ff1\u672c\u6cf0, \u7267\u7530\u61b2\u4e8c, \u77f3\u5ddd\u6d69\u53f2, \u974d\u5ca1\u614e\u592a\u90ce, \u9577\ufa11\u6167, \u5bae\u5ddd\u6b63\u7537, \u671b\u6708\u8f1d\u4e00. Treatment outcome of adjuvant radioiodine therapy for differentiated thyroid cancer. \u7b2c77\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a (2018. 4, \u6a2a\u6d5c)<br \/>\n14. \u6a2a\u4e95\u656c\u5f18, \u57ce\u6238\u8f1d\u4ec1, \u6851\u539f\u5948\u90fd\u7f8e, \u5e73\u4e95\u90a6\u660e, \u5ddd\u53e3\u76f4\u4eba, \u5009\u7530\u8056, \u4e2d\u6751\u58ee\u5fd7, \u57ce\u6238\u502b\u4e4b, \u5bae\u5ddd\u6b63\u7537, \u671b\u6708\u8f1d\u4e00. Relative and Absolute CT Perfusion Derived Myocardial Blood Flow Value Compared with Invasive Fractional Flow Reserve. \u7b2c77\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a (2018. 4, \u6a2a\u6d5c)<br \/>\n15. \u798f\u5c71\u76f4\u7d00,\u4e09\u6728\u5747,\u6cb3\u5185\u5b5d\u7bc4,\u5409\u7530\u548c\u6a39,\u9ad8\u9580\u653f\u5609,\u5bae\u672c\u52a0\u5948\u5b50,\u68ee\u5343\u5c0b,\u6751\u4e0a\u5fe0\u53f8,\u677e\u6728\u5f18\u91cf,\u77f3\u4e38\u826f\u5e83,\u9ad9\u6a4b\u5fe0\u7ae0,\u4e95\u4e0a\u6b66.\u672a\u7834\u88c2\u8133\u52d5\u8108\u7624\u306b\u5bfe\u3059\u308b\uff13\u8ef8\u65b9\u5411\u306eflow compensation\u3092\u7528\u3044\u305f3\u30c6\u30b9\u30e9MRA\u306e\u6709\u7528\u6027\u306b\u95a2\u3059\u308b\u691c\u8a0e. \u7b2c77\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a(2018.4,\u6a2a\u6d5c)<br \/>\n16. Okada K, Matsuda M, Hiratsuka Y, Tsuda T, Mochizuki T, et al. Dual-energy Breast CT on Preoperative Evaluation in the Patients with Breast Cancer: The Utility of Noise Reduced Monoenergetic Images. \u7b2c77\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a (2018. 4, \u6a2a\u6d5c)<br \/>\n17. Watanabe E, Miyagawa M, Hirai K, Yokoi T, Nakamura M, Kido T, Kido T, Kurata A, Mochizuki T. Characteristics of FDG uptake in the atria of patients with atrial fibrillation. \u7b2c77\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a (2018. 4, \u6a2a\u6d5c)<br \/>\n18. \u8239\u6728\u7fd4, \u671b\u6708\u8f1d\u4e00, \u4e0a\u54bd\u982d\u306b\u751f\u3058\u305fPorymorphous low-grade adenocarcinoma (PLGA)\u306e\uff11\u4f8b. \u7b2c47\u56de\u982d\u9838\u90e8\u30fb\u80f8\u90e8\u753b\u50cf\u7814\u7a76\u4f1a (2018. 5, \u6771\u4eac)<br \/>\n19. \u9ad8\u9580\u653f\u5609, \u77f3\u4e38\u826f\u5e83, \u798f\u5c71\u76f4\u7d00, \u6cb3\u5185\u5b5d\u7bc4, \u5409\u7530\u548c\u6a39, \u6751\u4e0a\u5fe0\u53f8, \u4e95\u4e0a\u6b66, \u4e09\u6728\u5747. Outcomes of bronchial artery embolization (BAE) at our hospital. \u7b2c47\u56de\u65e5\u672cIVR\u5b66\u4f1a\u7dcf\u4f1a (2018.5,\u6771\u4eac)<br \/>\n20. Hiroaki Tanaka, Naoto Kawaguchi, Tsuda Tanakahru, Mochizuki Teruhito. A case report of hepatolithiasis associated with coil.\u7b2c47\u56de\u65e5\u672cIVR\u5b66\u4f1a\u7dcf\u4f1a (2018.5.\u6771\u4eac)<br \/>\n21. \u7530\u4e2d\u5b8f\u660e. \u8853\u5f8c\u51fa\u8840\u306b\u5bfe\u3057\u30d0\u30a4\u30a2\u30d0\u30fc\u30f3\u7559\u7f6e\u6642\u306b\u813e\u52d5\u8108\u640d\u50b7\u3092\u5408\u4f75\u3057\u305f1\u75c7\u4f8b. \u7b2c6\u56de\u6551\u6025\u5916\u50b7IVR\u75c7\u4f8b\u691c\u8a0e\u4f1a.(2018.5, \u6771\u4eac)<br \/>\n22. \u677e\u7530\u6075,\u6d25\u7530\u5b5d\u6cbb,\u7530\u4e2d\u5b8f\u660e,\u671b\u6708\u8f1d\u4e00,\u516b\u6728\u5c02, \u7af9\u4e0b\u82f1\u6b21, \u65e5\u6d45\u967d\u4e00,\u77f3\u4e38\u5553, \u6e21\u90e8\u7950\u53f8,\u5317\u6fa4\u7406\u5b50,\u5317\u6fa4\u8358\u5e73.\u8178\u7d50\u77f3\u3092\u4f34\u3063\u305f\u5c0f\u8178\u30af\u30ed\u30fc\u30f3\u75c5\u306e\uff11\u4f8b.\u7b2c32\u56de\u8179\u90e8\u653e\u5c04\u7dda\u5b66\u4f1a(2018.5,\u3000\u938c\u5009)<br \/>\n23. \u677e\u7530\u6075,\u6d25\u7530\u5b5d\u6cbb,\u7530\u4e2d\u5b8f\u660e,\u671b\u6708\u8f1d\u4e00,\u57a3\u751f\u606d\u7950,\u677e\u91ce\u88d5\u4ecb,\u77f3\u4e38\u5553,\u5009\u7530\u7f8e\u6075,\u5317\u6fa4\u3000\u7406\u5b50,\u5317\u6fa4\u8358\u5e73.\u5c0f\u8178\u5e73\u6ed1\u7b4b\u816b\u306e1\u4f8b.\u7b2c32\u56de\u8179\u90e8\u653e\u5c04\u7dda\u5b66\u4f1a(2018.5\u3000\u938c\u5009)<br \/>\n24. \u677e\u7530\u6075, \u6d25\u7530\u5b5d\u6cbb, \u7530\u4e2d\u5b8f\u660e,\u3000\u671b\u6708\u8f1d\u4e00. \u8178\u7d50\u77f3\u3092\u4f34\u3063\u305f\u5c0f\u8178\u30af\u30ed\u30fc\u30f3\u75c5\u306e1\u4f8b\u3000\u7b2c32\u56de\u65e5\u672c\u8179\u90e8\u653e\u5c04\u7dda\u5b66\u4f1a.(2018. 5, \u938c\u5009)<br \/>\n25. \u677e\u7530\u6075, \u6d25\u7530\u5b5d\u6cbb, \u7530\u4e2d\u5b8f\u660e,\u3000\u671b\u6708\u8f1d\u4e00. \u5c0f\u8178\u5e73\u6ed1\u7b4b\u816b\u306e1\u4f8b\u7b2c32\u56de\u65e5\u672c\u8179\u90e8\u653e\u5c04\u7dda\u5b66\u4f1a.(2018. 5, \u938c\u5009)<br \/>\n26. \u7af9\u53e3\u5d07, \u6751\u7530\u771f\u592e, \u5ca9\u6751\u5353\u660e, \u539f\u4e95\u5ddd\u8c4a\u7ae0, \u798f\u4e95\u8061, \u677e\u5f71\u662d\u4e00. \u5c0f\u7db2\u539f\u767a\u5de8\u5927GIST\u306e\uff11\u4f8b. \u7b2c32\u56de\u65e5\u672c\u8179\u90e8\u653e\u5c04\u7dda\u5b66\u4f1a (2018. 5, \u938c\u5009)<br \/>\n27. \u7530\u4e2d\u5b8f\u660e. \u80ba\u56a2\u80de\u5185\u306b\u5408\u4f75\u3057\u305f\u80baAVM\u306e1\u4f8b.HHT Japan 2018.(2018.6, \u540d\u53e4\u5c4b)<br \/>\n28. Yuki Tanabe, Ranganath Praveen, Kay Fernando, Suhny Abbara, Rajiah Prabhakar, Teruhito Kido, Teruhito Mochizuki. 2\u5c64\u691c\u51fa\u5668CT\u306b\u3088\u308b\u4eee\u60f3\u5358\u7d14\u753b\u50cf\u3092\u7528\u3044\u305f\u30ab\u30eb\u30b7\u30a6\u30e0\u30b9\u30b3\u30a2\u30ea\u30f3\u30b0\u306e\u6709\u7528\u6027\u306b\u3064\u3044\u3066.\u7b2c87\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u7814\u7a76\u4f1a(2018.7, \u718a\u672c)<br \/>\n29. \u974d\u5ca1\u614e\u592a\u90ce,\u6ff1\u672c\u6cf0,\u7247\u5ca1\u6b63\u660e,\u77f3\u5ddd\u6d69\u53f2,\u9ad9\u7530\u7d00\u5b50,\u9577\ufa11\u6167,\u671b\u6708\u8f1d\u4e00\uff0eStage\u2160\u98df\u9053\u764c\u306b\u5bfe\u3059\u308b\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u4e88\u9632\u7684\u30ea\u30f3\u30d1\u7bc0\u9818\u57df\u7167\u5c04\u306e\u6709\u52b9\u6027\u306e\u691c\u8a0e\uff0eAdvanced Medical Imaging \u7814\u7a76\u4f1a 2018\uff0e(2018. 7, \u6771\u4eac)<br \/>\n30. \u6771\u91ce \u535a,\u9e7f\u5cf6 \u6587,\u963f\u90e8 \u5145\u4f2f,\u5ddd\u6761 \u6587\u9686,\u4e2d\u7530 \u8302,\u5bae\u7530 \u60a0\u91cc,\u8535\u7530 \u65e9\u7d00,\u8c9e\u5fb3 \u307f\u3061\u3053,\u7530\u4e2d \u653f\u884c,\u6c60\u6c34 \u6681\u5f66,\u4f0a\u7530 \u52dd\u5178,\u85e4\u679d \u88d5\u4e4b. \u30a2\u30c7\u30ce\u30b7\u30f3\u8ca0\u8377\u5fc3\u7b4b\u8840\u6d41\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u306b\u304a\u3051\u308b\u30ab\u30d5\u30a7\u30a4\u30f3\u5236\u9650\u6642\u9593\u306e\u5f71\u97ff. \u7b2c28\u56de\u65e5\u672c\u5fc3\u81d3\u6838\u533b\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a (2018. 7, \u6771\u4eac)<br \/>\n31. M Matsuda, T Tsuda, K. Okada T. Kido T. Tanaka Y, Shiraishi H. Suekuni T, Mochizuki T. The utility of R2* map acquired by IDEAL-IQ for the evaluation of hepatic function.\u7b2c46\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\u3000(2018. 9, \u91d1\u6ca2)<br \/>\n32. \u6cb3\u5185\u5b5d\u7bc4, \u7530\u9089\u88d5\u8cb4, \u57ce\u6238\u8f1d\u4ec1, \u6851\u539f\u5948\u90fd\u7f8e, \u5409\u7530\u548c\u6a39, \u5e73\u4e95\u90a6\u660e, \u677e\u7530\u5353\u4e5f, \u57ce\u6238\u502b\u4e4b, \u5009\u7530\u8056, \u5bae\u5ddd\u6b63\u7537, \u671b\u6708\u8f1d\u4e00. Dynamic Perfusion CT\u306b\u3088\u308b\u5fc3\u7b4b\u8840\u6d41\u5b9a\u91cf\u8a55\u4fa1\u306b\u304a\u3051\u308b\u30c6\u30ea\u30c8\u30ea\u30fc\u89e3\u6790\u4f75\u7528\u306e\u6709\u7528\u6027 \u7b2c12\u56deSCCT\u7814\u7a76\u4f1a(2018.9 \u6771\u4eac)<br \/>\n33. \u7530\u4e2d\u5b8f\u660e,\u5ddd\u53e3\u76f4\u4eba,\u6d25\u7530\u5b5d\u6cbb,\u671b\u6708\u8f1d\u4e00, \u516b\u6749\u3000\u5de7. \u6b63\u4e2d\u5f13\u72b6\u9771\u5e2f\u5727\u8feb\u306b\u3088\u308b\u8179\u8154\u52d5\u8108\u8d77\u59cb\u90e8\u72ed\u7a84\u306b\u30b9\u30c6\u30f3\u30c8\u7559\u7f6e\u3092\u884c\u3063\u305f\u81b5\u982d\u90e8\u764c\u306e1\u4f8b. \u7b2c59\u56de\u65e5\u672c\u8108\u7ba1\u5b66\u4f1a\u7dcf\u4f1a.(2018.10.\u5e83\u5cf6)<br \/>\n34. \u5175\u982d\u670b\u5b50. CT\uff0cMR\u3067\u307f\u308b\u809d\u7d30\u80de\u764c\u306e\u6cbb\u7642\u5f8c\u5909\u5316.\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c31\u56de\u5b66\u8853\u5927\u4f1a (2018.10, \u4eac\u90fd)<br \/>\n35. \u974d\u5ca1\u614e\u592a\u90ce,\u6ff1\u672c\u6cf0,\u5927\u5185\u7dbe\u9e7f,\u77f3\u5ddd\u6d69\u53f2,\u9ad9\u7530\u7d00\u5b50,\u9577\ufa11\u6167,\u671b\u6708\u8f1d\u4e00\uff0e\u80ba\u764c\u306b\u5bfe\u3059\u308b\u7de9\u548c\u7684\u80f8\u90e8\u7167\u5c04\u306e\u6cbb\u7642\u6210\u7e3e\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c31\u56de\u5b66\u8853\u5927\u4f1a\uff0e(2018. 10, \u4eac\u90fd)<br \/>\n36. \u8239\u6728\u7fd4. \u982d\u9838\u90e8\u611f\u67d3\u6027\u75be\u60a3\u306e\u753b\u50cf\u8a3a\u65ad. \u7b2c54\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a (2018.10, \u798f\u5ca1)<br \/>\n37. \u9577\ufa11\u6167, \u6ff1\u672c\u6cf0, \u5927\u5185\u7dbe\u9e7f, \u77f3\u5ddd\u6d69\u53f2, \u974f\u5ca1\u614e\u592a\u90ce, \u9ad8\u7530\u7d00\u5b50, \u671b\u6708\u8f1d\u4e00. \u5b50\u5bae\u9838\u764c\u306b\u5bfe\u3059\u308bCT based IGBT\u306e\u521d\u671f\u7d4c\u9a13. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c31\u56de\u5b66\u8853\u5927\u4f1a (2018. 10, \u4eac\u90fd)<br \/>\n38. \u9ad8\u7530\u7d00\u5b50, \u5bae\u5ddd\u6b63\u7537, \u6e21\u90e8\u7b11\u9e97, \u77f3\u6751\u96bc\u4eba, \u5ddd\u53e3\u76f4\u4eba, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1, \u671b\u6708\u8f1d\u4e00. Three cases of differentiated thyroid cancer with brain metastasis after radioiodine therapy. \u7b2c58\u4f1a\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2018. 11, \u6c96\u7e04)<br \/>\n39. \u6e21\u90e8\u7b11\u9e97\uff0c\u5bae\u5ddd\u6b63\u7537, \u77f3\u6751\u96bc\u4eba, \u57ce\u6238\u3000\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u671b\u6708\u8f1d\u4e00\uff0e\u5fc3\u623f\u7d30\u52d5\u60a3\u8005\u306b\u304a\u3051\u308b\u5fc3\u81d3\u3078\u306e FDG \u96c6\u7a4d\u3068\u96c6\u7a4d\u306b\u95a2\u9023\u3059\u308b\u56e0\u5b50\u306e\u691c\u8a0e\uff0e\u7b2c58\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a(2018\uff0e11\uff0c\u6c96\u7e04)<br \/>\n40. \u5409\u7530\u548c\u6a39,\u7530\u908a\u88d5\u8cb4,\u6cb3\u5185\u5b5d\u7bc4,\u5e73\u4e95\u90a6\u660e,\u4e2d\u6751\u58ee\u5fd7,\u677e\u7530\u5353\u4e5f,\u57ce\u6238\u502b\u4e4b,\u57ce\u6238\u8f1d\u4ec1,\u5009\u7530\u8056,\u671b\u6708\u8f1d\u4e00. \u80a5\u5927\u578b\u5fc3\u7b4b\u75c7\u3092\u80cc\u666f\u3068\u3057\u305f\u5fc3\u5c16\u90e8\u7624,\u51a0\u52d5\u8108\u5de6\u5ba4\u763b\u304c\u7591\u308f\u308c\u305f\u4e00\u4f8b. \u7b2c87\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u7814\u7a76\u4f1a (2018. 7, \u718a\u672c)<br \/>\n41. Hirata M, Iwano S, Nakamura S, Akamune A, Watanabe R. Development of applications for smart devices to assist IVR practice. \u7b2c47\u56de\u65e5\u672cIVR\u5b66\u4f1a\u7dcf\u4f1a(2018. 5 \u6771\u4eac)<br \/>\n42. Hirata M, Iwano S, Nakamura S, Akamune A, Ogawa A, Watanabe R. A case of percutaneous drainage for infected Walled-off Necrosis facilitated with introducer sheath. \u7b2c47\u56de\u65e5\u672cIVR\u5b66\u4f1a\u7dcf\u4f1a(2018. 5 \u6771\u4eac)<br \/>\n43. \u5ca1\u7530\u52a0\u5948\u5b50,\u677e\u7530\u6075,\u6d25\u7530\u5b5d\u6cbb,\u57ce\u6238\u8f1d\u4ec1,\u671b\u6708\u8f1d\u4e00,\u897f\u5c71\u5149. \u4e73\u764c\u8853\u524d\u8a55\u4fa1\u306b\u304a\u3051\u308bDual-energy CT\u3092\u7528\u3044\u3066\u4f5c\u6210\u3055\u308c\u305f\u4eee\u60f3\u5358\u8272X\u7dda\u753b\u50cf\u306e\u6709\u7528\u6027\u306b\u3064\u3044\u3066. SAMI 2018 (2018. 7, \u6771\u4eac)<br \/>\n44. \u6a2a\u4e95\u656c\u5f18, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u57ce\u6238\u502b\u4e4b, \u5bae\u5ddd\u6b63\u7537, \u671b\u6708\u8f1d\u4e00, \u4e09\u6728\u5747. CT\u704c\u6d41\u753b\u50cf\u304b\u3089\u7b97\u51fa\u3055\u308c\u308b\u704c\u6d41\u6bdb\u7d30\u8840\u7ba1\u5bb9\u7a4d\u306e\u51a0\u52d5\u8108\u72ed\u7a84\u8a3a\u65ad\u306b\u304a\u3051\u308b\u6709\u7528\u6027\u8a55\u4fa1. SAMI2018 (2018. 7, \u6771\u4eac)<br \/>\n45. \u5fb3\u6c38\u4f38\u5b50\uff0c\u5c71\u672c\u96c4\u592a\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u6850\u5c71\u90c1\u5b50\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587\uff0c\u85e4\u672c\u60a6\u5b50\uff0c\u7af9\u539f\u548c\u5b8f\uff0c\u5bfa\u672c\u5178\u5f18\uff0e\u5185\u819c\u75c7\u6027\u56a2\u80de\u7531\u6765\u306e\u60aa\u6027\u816b\u760d\u3068\u306e\u9451\u5225\u304c\u56f0\u96e3\u3067\u3042\u3063\u305f\u8ee2\u79fb\u6027\u5375\u5de3\u816b\u760d\u306e1\u4f8b\uff0e\u7b2c32\u56de\u65e5\u672c\u8179\u90e8\u653e\u5c04\u7dda\u5b66\u4f1a (2018.5.25, \u938c\u5009)<br \/>\n46. \u5c71\u672c\u96c4\u592a\uff0c\u5fb3\u6c38\u4f38\u5b50\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u6850\u5c71\u90c1\u5b50\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587\uff0c\u6a2a\u5c71\u8cb4\u7d00\uff0c\u7af9\u539f\u548c\u5b8f\uff0c\u5bfa\u672c\u5178\u5f18\uff0e\u56a2\u80de\u5909\u6027\u3068FDG\u96c6\u7a4d\u4ea2\u9032\u3092\u751f\u3058\u305f\u83a2\u819c\u7d30\u80de\u816b\u306e1\u4f8b\uff0e\u7b2c32\u56de\u65e5\u672c\u8179\u90e8\u653e\u5c04\u7dda\u5b66\u4f1a (2018.5.25, \u938c\u5009)<br \/>\n47. \u5c71\u672c\u96c4\u592a\uff0e\u75c7\u4f8b\u691c\u8a0e\u4f1a\uff1a\u767d\u72d0\u3068\u3044\u3063\u3057\u3087\u306b\u63a2\u3057\u51fa\u3059PET\u753b\u50cf\u306e\u6df1\u5c64\uff0ePET\u30b5\u30de\u30fc\u30bb\u30df\u30ca\u30fc2018 in \u5c71\u53e3\u6e6f\u7530\u6e29\u6cc9(2018.8.24, \u5c71\u53e3)<br \/>\n48. \u798f\u5c71\u76f4\u7d00,\u5ddd\u53e3\u76f4\u4eba,\u4e95\u4e0a\u6b66,\u5ca1\u5c71\u82f1\u6a39,\u4e09\u6728\u5747. 13N\u30a2\u30f3\u30e2\u30cb\u30a2PET\u306e\u89e3\u91c8\u306b\u6ce8\u610f\u3057\u3088\u3046! PET\u30b5\u30de\u30fc\u30bb\u30df\u30ca\u30fc2018(2018.8,\u5c71\u53e3)<br \/>\n49. \u5fb3\u6c38\u4f38\u5b50\uff0c\u5c71\u672c\u96c4\u592a\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u6850\u5c71\u90c1\u5b50\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587\uff0c\u85e4\u672c\u60a6\u5b50\uff0c\u7af9\u539f\u548c\u5b8f\uff0c\u5bfa\u672c\u5178\u5f18\uff0e\u826f\u60aa\u6027\u306e\u9451\u5225\u304c\u56f0\u96e3\u3067\u3042\u3063\u305f\u5375\u5de3\u306e\u817a\u7dda\u7dad\u816b\u69d8\u660e\u7d30\u80de\u764c\u306e1\u4f8b\uff0eJSAWI2018, 19th Annual Symposium (2018.8, \u6de1\u8def)<br \/>\n50. \u5409\u7530\u548c\u6a39,\u7530\u908a\u88d5\u8cb4,\u6d66\u5ca1\u5927\u77e5,\u6851\u539f\u5948\u90fd\u7f8e,\u6cb3\u5185\u5b5d\u7bc4,\u5e73\u4e95\u90a6\u660e\u677e\u7530\u5353\u4e5f,\u57ce\u6238\u502b\u4e4b,\u57ce\u6238\u8f1d\u4ec1,\u5009\u7530\u8056,\u5bae\u5ddd\u6b63\u7537,\u671b\u6708\u8f1d\u4e00. Iterative Model Reconstruction\u304c\u30c0\u30a4\u30ca\u30df\u30c3\u30af\u5fc3\u7b4bCT perfusion\u753b\u50cf\u306e\u753b\u8cea\u3068MBF\u306b\u53ca\u307c\u3059\u5f71\u97ff\u306b\u3064\u3044\u3066 . \u7b2c12\u56deSCCT\u7814\u7a76\u4f1a (2018.9.\u6771\u4eac)<br \/>\n51. \u5009\u7530\u8056\uff0e(\u6307\u540d\u8b1b\u6f14) SCCT \u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3068 CAD-RADS \u304b\u3089\u5b66\u3076\u5fc3\u81d3 CT \u30ec\u30dd\u30fc\u30c8\u306e\u6a19\u6e96\u5316\uff0e\u7b2c66\u56de\u65e5\u672c\u5fc3\u81d3\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(2018, 9\uff0c\u5927\u962a)<br \/>\n52. \u4e09\u597d\u3000\u4ea8\uff0c\u5009\u7530\u3000\u8056\uff0e(\u6307\u540d\u8b1b\u6f14)\u5fc3\u81d3CT \u306b\u3088\u308b\u51a0\u52d5\u8108\u75be\u60a3\u306e\u5fc3\u7b4b\u865a\u8840\u8a55\u4fa1\uff0e\u7b2c66\u56de\u65e5\u672c\u5fc3\u81d3\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(2018, 9\uff0c\u5927\u962a)<br \/>\n53. \u798f\u5c71\u76f4\u7d00,\u4e09\u6728\u5747,\u5e74\u68ee\u65e6,\u4e2d\u9808\u8cc0,\u9ad8\u9580\u653f\u5609,\u5ddd\u7551\u52a0\u5948\u5b50,\u6a2a\u4e95\u656c\u5f18,\u68ee\u5343\u5c0b,\u6751\u4e0a\u5fe0\u53f8,\u677e\u6728\u5f18\u91cf,\u77f3\u4e38\u826f\u5e83,\u9ad9\u6a4b\u5fe0\u7ae0,\u4e95\u4e0a\u6b66. 3T-MRA\u3092\u7528\u3044\u305f\u8133\u52d5\u8108\u72ed\u7a84\u306e\u5f62\u614b\u8a55\u4fa1\uff1a3\u8ef8\u65b9\u5411Flow Compensation\u306e\u6709\u7528\u6027. \u7b2c46\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a(2018.9,\u91d1\u6ca2)<br \/>\n54. \u6a2a\u4e95\u656c\u5f18, \u4e09\u6728\u5747, \u798f\u5c71\u76f4\u7d00, \u4e95\u4e0a\u6b66, \u5ca9\u7530\u771f\u6cbb, \u5927\u4e0a\u53f2\u6717. T2-SPACE\u306b\u3088\u308b\u975e\u4ea4\u901a\u6027\u6c34\u982d\u75c7\u306e\u5185\u8996\u93e1\u4e0b\u7b2c\u4e09\u8133\u5ba4\u5e95\u958b\u7a93\u8853\u5f8c\u8a55\u4fa1. \u7b2c46\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a (2018. 9, \u91d1\u6ca2)<br \/>\n55. \u795e\u5d0e \u535a\u5145\uff0c\u4e0a\u6d25 \u5b5d\u592a\u90ce\uff0c\u7247\u5ca1 \u6b63\u660e. \u4e73\u764c\u9aa8\u8ee2\u79fb\u306b\u5bfe\u3059\u308b\u7de9\u548c\u7684\u653e\u5c04\u7dda\u6cbb\u7642\u5f8c\u306e\u4e88\u5f8c\u56e0\u5b50\u306e\u691c\u8a0e. \u7b2c31\u56de\u65e5\u672c\u653e\u5c04\u816b\u760d\u5b66\u4f1a(2018.10, \u4eac\u90fd)<br \/>\n56. \u6850\u5c71\u90c1\u5b50\uff0c\u83c5\u539f\u656c\u6587\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u5fb3\u6c38\u4f38\u5b50\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u5c71\u672c\u96c4\u592a\uff0c\u9752\u5100\u5065\u4e8c\u90ce\uff0c\u5bfa\u672c\u5178\u5f18\uff0e\u826f\u304f\u4f3c\u305f\u753b\u50cf\u6240\u898b\u3092\u793a\u3057\u305f\u4e21\u5074\u4e73\u817a\u816b\u7624\u306e\u4e00\u4f8b\uff0e\u7b2c54\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a(2018.10\uff0c\u798f\u5ca1)<br \/>\n57. \u5c71\u672c\u96c4\u592a\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u6850\u5c71\u90c1\u5b50\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587\uff0c\u6d45\u6728\u5f70\u5247\uff0c\u7058\u91ce\u6210\u4eba\uff0c\u6749\u672c\u9f8d\u58eb\u90ce\uff0c\u5bfa\u672c\u5178\u5f18\uff0c\u798f\u5ca1\u9806\u4e5f\uff0e\u5065\u8a3a\u3092\u5951\u6a5f\u306b\u767a\u898b\u3055\u308c\u305f\u985e\u4e0a\u76ae\u8840\u7ba1\u5185\u76ae\u816b\u306e1\u4f8b\uff0e\u7b2c32\u56de\u80f8\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a(2018.10\uff0c\u798f\u5ca1)<br \/>\n58. \u7267\u7530\u61b2\u4e8c, \u6d66\u5cf6\u96c4\u4ecb, \u5ca1\u7530\u77e5\u4e45, \u6e21\u90e8\u7b11\u9e97, \u4e09\u597d\u88d5\u7f8e, \u4e95\u4e0a\u7950\u99ac, \u68b6\u539f\u8aa0, \u677e\u7530\u5065, \u767d\u77f3\u731b, \u83ca\u6c60\u6075\u4e00. \u5f53\u9662\u306b\u304a\u3051\u308b\u809b\u9580\u6241\u5e73\u4e0a\u76ae\u764c\u6cbb\u7642\u75c7\u4f8b\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e. \u7b2c54\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a(2018. 10, \u798f\u5ca1)<br \/>\n59. \u5bae\u5ddd \u6b63\u7537. FDG-PET\u691c\u67fb\u306e\u5fc3\u81d3\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u8a3a\u7642\u306b\u304a\u3051\u308b\u4f4d\u7f6e\u3065\u3051. \u7b2c38\u56de\u65e5\u672c\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\/\u8089\u82bd\u816b\u6027\u75be\u60a3\u5b66\u4f1a\u7dcf\u4f1a (2018.11, \u6771\u4eac)<br \/>\n60. \u5c0f\u91ce\u525b\u53f2\uff0c\u6a2a\u5cf0\u572d\uff0c\u5fb3\u6c38\u4f38\u5b50\uff0c\u83c5\u539f\u656c\u6587\uff0eTOF\u642d\u8f09 \u5927\u53e3\u5f84PET\/CT\u88c5\u7f6e\u306b\u304a\u3051\u308b\u4f53\u683c\u6307\u6a19\u3092\u8003\u616e\u3057\u305f\u53ce\u96c6\u6642\u9593\u306e\u521d\u671f\u691c\u8a0e\uff0e\u7b2c58\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a(2018.11, \u6c96\u7e04)<br \/>\n61. \u5c71\u672c\u96c4\u592a\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u5fb3\u6c38\u4f38\u5b50\uff0c\u6850\u5c71\u90c1\u5b50\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587\uff0c\u7af9\u539f\u548c\u5b8f\uff0c\u6d45\u6728\u5f70\u5247\uff0c\u5bfa\u672c\u5178\u5f18\uff0e\u591a\u767a\u8ee2\u79fb\u3092\u5951\u6a5f\u306b\u767a\u898b\u3055\u308c,FDG\u96c6\u7a4d\u4e4f\u3057\u304f,\u30aa\u30af\u30c8\u30ec\u30aa\u30b9\u30ad\u30e3\u30f3\u3067\u96c6\u7a4d\u4ea2\u9032\u3092\u793a\u3057\u305f\u76f4\u8178NET\u306e1\u4f8b\uff0e\u7b2c58\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a(2018.11, \u6c96\u7e04)<br \/>\n62. \u6e21\u90e8 \u7b11\u9e97, \u5bae\u5ddd \u6b63\u7537, \u5e73\u4e95 \u90a6\u660e, \u6a2a\u4e95 \u656c\u5f18, \u5c0f\u5ddd \u907c, \u5ddd\u53e3 \u76f4\u4eba, \u57ce\u6238 \u502b\u4e4b, \u57ce\u6238 \u8f1d\u4ec1, \u5009\u7530 \u8056, \u671b\u6708 \u8f1d\u4e00. \u5fc3\u623f\u7d30\u52d5\u60a3\u8005\u306b\u304a\u3051\u308bF-18 FDG\u5fc3\u96c6\u7a4d\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e. \u7b2c58\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2018.11, \u6c96\u7e04)<br \/>\n63. \u5ddd\u53e3 \u76f4\u4eba, \u5bae\u5ddd \u6b63\u7537, \u671b\u6708 \u8f1d\u4e00. et al. \u30a2\u30f3\u30e2\u30cb\u30a2PET\u3092\u7528\u3044\u305fCFR ratio\u306b\u3088\u308b\u518d\u704c\u6d41\u7642\u6cd5\u5f8c\u306e\u6cbb\u7642\u52b9\u679c\u5224\u5b9a. \u7b2c58\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2018.11, \u6c96\u7e04)<br \/>\n64. \u9ad8\u7530\u7d00\u5b50, \u5bae\u5ddd \u6b63\u7537, \u671b\u6708 \u8f1d\u4e00. et al. \u7532\u72b6\u817a\u764c\u306b\u5bfe\u3059\u308b\u653e\u5c04\u6027\u30e8\u30fc\u30c9\u5185\u7528\u7642\u6cd5\u7d4c\u904e\u4e2d\u306b\u80fd\u8ee2\u79fb\u3092\u6765\u3057\u305f\u4e09\u4f8b. \u7b2c58\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2018.11, \u6c96\u7e04)<br \/>\n65. \u5fb3\u6c38\u4f38\u5b50\uff0c\u5c71\u672c\u96c4\u592a\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u6850\u5c71\u90c1\u5b50\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587\uff0e \u539f\u767a\u5de3\u3068\u8ee2\u79fb\u5de3\u3067\u306eFDG\u96c6\u7a4d\u306e\u4e56\u96e2\u306b\u3064\u3044\u3066\uff0e\u7b2c58\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a(2018.11, \u6c96\u7e04)<br \/>\n<a name=\"07\"><\/a><span style=\"color: #d391a8;\">\u25cf<\/span> \u56fd\u5185\u5b66\u4f1a\uff08\u5730\u65b9\u4f1a\uff09<br \/>\n1. \u798f\u5c71\u76f4\u7d00,\u77f3\u4e38\u826f\u5e83,\u6cb3\u5185\u5b5d\u7bc4,\u5409\u7530\u548c\u6a39,\u9ad8\u9580\u653f\u5609,\u6751\u4e0a\u5fe0\u53f8,\u4e95\u4e0a\u6b66,\u4e09\u6728\u5747. \u9396\u9aa8\u4e0b\u52d5\u8108\u306e\u5206\u679d\u304b\u3089\u306e\u51fa\u8840\u306b\u5bfe\u3057\u3066TAE\u3092\u65bd\u884c\u3057\u305f\uff13\u4f8b.\u3000\u7b2c13\u56de\u611b\u5a9bIVR\u7814\u7a76\u4f1a(2018.3,\u677e\u5c71)<br \/>\n2. \u6a2a\u4e95\u656c\u5f18, \u57ce\u6238\u8f1d\u4ec1, \u6851\u539f\u5948\u90fd\u7f8e, \u7530\u908a\u88d5\u8cb4, \u5009\u7530\u8056, \u4e2d\u6751\u58ee\u5fd7, \u57ce\u6238\u502b\u4e4b, \u671b\u6708\u8f1d\u4e00. \u8ca0\u8377\u30c0\u30a4\u30ca\u30df\u30c3\u30af\u5fc3\u7b4bCT perfusion\u691c\u67fb\u306b\u304a\u3051\u308b\u76f8\u5bfe\u5024\u3092\u7528\u3044\u305f\u5fc3\u7b4b\u8840\u6d41\u5b9a\u91cf\u8a55\u4fa1\u306e\u691c\u8a0e. \u7b2c38\u56de\u305b\u3068\u3046\u3061\u5fc3\u81d3CT\u30fbMR\u52c9\u5f37\u4f1a (2018. 3, \u677e\u5c71)<br \/>\n3. \u5409\u7530\u548c\u6a39,\u7530\u908a\u88d5\u8cb4,\u6851\u539f\u5948\u90fd\u7f8e,\u6cb3\u5185\u5b5d\u7bc4,\u5e73\u4e95\u90a6\u660e,\u4e2d\u6751\u58ee\u5fd7,\u677e\u7530\u5353\u4e5f,\u57ce\u6238\u502b\u4e4b,\u57ce\u6238\u8f1d\u4ec1,\u5009\u7530\u8056,\u5bae\u5ddd\u6b63\u7537,\u671b\u6708\u8f1d\u4e00. \u51a0\u52d5\u8108\u5de6\u5ba4\u763b\u304c\u7591\u308f\u308c\u305f\u4e00\u4f8b. \u3057\u307e\u306a\u307f\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9 (2018.6,\u611b\u5a9b)<br \/>\n4. \u5c71\u672c\u96c4\u592a\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u5fb3\u6c38\u4f38\u5b50\uff0c\u6850\u5c71\u90c1\u5b50\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587\uff0c\u9580\u7530\u4f38\u4e5f\uff0c\u5bfa\u672c\u5178\u5f18\uff0e\u5589\u982d\u306b\u767a\u751f\u3057\u305fsolitary fibrous tumor\u306e1\u4f8b\uff0e\u7b2c130\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a(2018.6, \u51fa\u96f2)<br \/>\n5. \u7267\u7530\u61b2\u4e8c, \u6d66\u5cf6\u96c4\u4ecb, \u5ca1\u7530\u77e5\u4e45, \u6e21\u90e8\u7b11\u9e97, \u4e09\u597d\u88d5\u7f8e, \u4e95\u4e0a\u7950\u99ac, \u68b6\u539f\u8aa0, \u677e\u7530\u5065, \u6a2a\u7530\u667a\u884c, \u5927\u57ce\u7531\u7f8e, \u83ca\u6c60\u6075\u4e00. \u81b5Spindle Cell Carcinoma\u306b\u5bfe\u3057\u3066\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u304c\u8457\u52b9\u3057\u305f\u4e00\u4f8b. \u7b2c130\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a \u4e2d\u56fd\uff65\u56db\u56fd\u5730\u65b9\u4f1a(2018. 6, \u5cf6\u6839)<br \/>\n6. \u6a2a\u4e95\u656c\u5f18, \u4e95\u4e0a\u6b66, \u798f\u5c71\u76f4\u7d00, \u4e2d\u9808\u8cc0\u4f73\u592e\u91cc, \u5e74\u68ee\u4e98, \u9ad8\u9580\u653f\u5609, \u68ee\u5343\u5c0b, \u6751\u4e0a\u5fe0\u53f8, \u77f3\u4e38\u826f\u5e83, \u9ad8\u6a4b\u5fe0\u7ae0, \u4e09\u6728\u5747, \u77f3\u6238\u8c37\u6d69. \u51a0\u52d5\u8108\u80ba\u52d5\u8108\u763b\u306b\u5408\u4f75\u3057\u305f\u7570\u5e38\u8840\u7ba1\u7531\u6765\u306e\u52d5\u8108\u7624\u7834\u88c2\u3092\u304d\u305f\u3057\u305f\u4e00\u4f8b. \u7b2c130\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a (2018. 6, \u5cf6\u6839)<br \/>\n7. \u5ca9\u91ce\u7965\u5b50,\u5e73\u7530\u96c5\u662d,\u53cb\u677e\u5b97\u53f2,\u4e2d\u6751\u8aa0\u6cbb,\u8d64\u5b97\u660e\u4e45,\u6e21\u908a\u826f\u5e73. \u5de6\u534a\u7d50\u8178\u5207\u9664\u8853\u5f8c\u306b\u96e3\u6cbb\u6027\u306e\u865a\u8840\u6027\u8178\u708e\u3092\u6765\u3057\u305f\u4e0b\u8178\u9593\u819c\u52d5\u9759\u8108\u30b7\u30e3\u30f3\u30c8\u306e1\u4f8b. \u7b2c130\u56de\u65e5\u672c\u653e\u5c04\u7dda\u5b66\u4f1a \u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a(2018, 6. \u5cf6\u6839)<br \/>\n8. \u974d\u5ca1\u614e\u592a\u90ce,\u6ff1\u672c\u6cf0,\u5927\u5185\u7dbe\u9e7f,\u77f3\u5ddd\u6d69\u53f2,\u9ad9\u7530\u7d00\u5b50,\u9577\ufa11\u6167,\u671b\u6708\u8f1d\u4e00\uff0e\u6c17\u9053\u72ed\u7a84\u30fb\u9589\u585e\u3092\u6765\u305f\u3057\u305f\u80ba\u764c\u75c7\u4f8b\u306b\u5bfe\u3059\u308b\u7de9\u548c\u7684\u653e\u5c04\u7dda\u6cbb\u7642\u6210\u7e3e\uff0e\u7b2c130\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56db\u56fd\u5730\u65b9\u4f1a\uff0e(2018. 6, \u5cf6\u6839)<br \/>\n9. \u6cb3\u5185\u5b5d\u7bc4, \u7530\u9089\u88d5\u8cb4, \u6851\u539f\u5948\u90fd\u7f8e, \u5409\u7530\u548c\u6a39, \u5e73\u4e95\u90a6\u660e, \u4e2d\u6751\u58ee\u5fd7, \u677e\u7530\u5353\u4e5f, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u5bae\u5ddd\u6b63\u7537, \u671b\u6708\u8f1d\u4e00. \u51a0\u52d5\u8108\u75be\u60a3\u306e\u6a5f\u80fd\u7684\u8a55\u4fa1\u306b\u304a\u3051\u308b\u5fc3\u81d3CT\u306e\u6709\u7528\u6027. \u7b2c130\u56de \u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u79d1\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a \u7b2c53\u56de\u65e5\u672c\u6838\u533b\u5b66\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a. (2018.6 \u5cf6\u6839)<br \/>\n10. \u795e\ufa11 \u535a\u5145\uff0c\u7247\u5ca1 \u6b63\u660e\uff0c\u4e0a\u6d25 \u5b5d\u592a\u90ce. \u9060\u9694\u8ee2\u79fb\u3092\u6709\u3059\u308b\u98df\u9053\u764c\u75c7\u4f8b\u306b\u304a\u3051\u308b\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u56a5\u4e0b\u969c\u5bb3\u306b\u5bfe\u3059\u308b\u52b9\u679c. 130\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a(2018. 6, \u5fb3\u5cf6)<br \/>\n11. \u5c0f\u91ce\u525b\u53f2\uff0c\u5fb3\u6c38\u4f38\u5b50\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587\uff0eTOF\u642d\u8f09 \u30e9\u30fc\u30b8\u30dc\u30a2PET\/CT\u88c5\u7f6e\u306b\u304a\u3051\u308b\u81f3\u9069\u53ce\u96c6\u6761\u4ef6\u306e\u691c\u8a0e\uff0e\u7b2c53\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a(2018.6.16, \u51fa\u96f2)<br \/>\n12. \u5c71\u672c\u96c4\u592a\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u5fb3\u6c38\u4f38\u5b50\uff0c\u6850\u5c71\u90c1\u5b50\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587\uff0c\u91ce\u5d0e\u529f\u96c4\uff0c\u82b1\u5ddd\u6d69\u4e4b\uff0c\u5bfa\u672c\u5178\u5f18\uff0e\u8208\u5473\u3042\u308bFDG\u96c6\u7a4d\u3092\u793a\u3057\u305f\u98df\u9053\u795e\u7d4c\u9798\u816b\u3068\u30ea\u30f3\u30d1\u7bc0\u816b\u5927\u306e1\u4f8b\uff0e\u7b2c53\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a(2018.6, \u51fa\u96f2)<br \/>\n13. \u7530\u4e2d\u5b8f\u660e,\u5ddd\u53e3\u76f4\u4eba,\u671b\u6708\u8f1d\u4e00, \u516b\u6749\u3000\u5de7. \u7dcf\u809d\u52d5\u8108\u7624\u306b\u5bfe\u3057\u3066\u30b3\u30a4\u30eb\u585e\u6813\u3068\u30d0\u30a4\u30a2\u30d0\u30fc\u30f3\u30b9\u30c6\u30f3\u30c8\u30b0\u30e9\u30d5\u30c8\u4f75\u7528\u306b\u3066\u6cbb\u7642\u3057\u305f1\u4f8b. \u65e5\u672c\u8840\u7ba1\u5916\u79d1\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a\u7b2c49\u56de\u7dcf\u4f1a.(2018.7.\u7c73\u5b50)<br \/>\n14. \u7530\u4e2d\u5b8f\u660e,\u5ddd\u53e3\u76f4\u4eba,\u671b\u6708\u8f1d\u4e00. DeFrictor Nano Catheter\u3092\u7528\u3044\u305fNBCA\u585e\u6813\u8853\u306e1\u4f8b.\u7b2c32\u56de\u4e2d\u56fd\u56db\u56fdIVR\u7814\u7a76\u4f1a.(2018.10.\u5ca1\u5c71)<br \/>\n15. \u7530\u4e2d\u5b8f\u660e,\u5ddd\u53e3\u76f4\u4eba,\u671b\u6708\u8f1d\u4e00,\u6728\u4e0b\u5149\u535a, \u68b6\u539f\u8ce2\u53f8,\u5c71\u4e0a\u5353\u58eb.\u5927\u817f\u9759\u8108\u30a2\u30d7\u30ed\u30fc\u30c1\u3067\u53f3\u526f\u809d\u9759\u8108\u304b\u3089TIPS\u3092\u65bd\u884c\u3057\u305f\u96e3\u6cbb\u6027\u8179\u6c34\u306e1\u4f8b. \u7b2c32\u56de\u4e2d\u56fd\u56db\u56fdIVR\u7814\u7a76\u4f1a.(2018.10.\u5ca1\u5c71)<br \/>\n16. \u68ee\u5ddd\u53cb\u90ce,\u7530\u4e2d\u5b8f\u660e,\u6cb3\u5185\u7fa9\u5f18,\u5ddd\u53e3\u76f4\u4eba,\u671b\u6708\u8f1d\u4e00. \u6c17\u7ba1\u652f\u52d5\u8108\u585e\u6813\u8853\u3092\u65bd\u884c\u3057\u305f\u7279\u767a\u6027\u5580\u8840\u75c7\u306e1\u4f8b. \u7b2c32\u56de\u4e2d\u56fd\u56db\u56fdIVR\u7814\u7a76\u4f1a.(2018.10.\u5ca1\u5c71)<br \/>\n17. \u798f\u5c71\u76f4\u7d00,\u77f3\u4e38\u826f\u5e83,\u9ad8\u9580\u653f\u5609,\u6a2a\u4e95\u656c\u5f18,\u6751\u4e0a\u5fe0\u53f8,\u4e95\u4e0a\u6b66,\u4e09\u6728\u5747. \u4eee\u6027\u7624\u3092\u4f34\u3046\u9aa8\u76e4\u90e8\u306e\u5916\u50b7\u6027\u52d5\u9759\u8108\u763b(AVF)\u306b\u5bfe\u3057\u3066\u30b3\u30a4\u30eb\u585e\u6813\u8853\u3092\u65bd\u884c\u3057\u305f\uff11\u4f8b.\u3000\u7b2c32\u56de\u4e2d\u56db\u56fdIVR\u7814\u7a76\u4f1a(2018.10,\u5ca1\u5c71)<br \/>\n18. \u5409\u7530\u548c\u6a39,\u7530\u908a\u88d5\u8cb4,\u6d66\u5ca1\u5927\u77e5,\u6851\u539f\u5948\u90fd\u7f8e,\u6cb3\u5185\u5b5d\u7bc4,\u5e73\u4e95\u90a6\u660e,\u677e\u7530\u5353\u4e5f,\u5ddd\u53e3\u76f4\u4eba,\u5009\u7530\u8056,\u57ce\u6238\u502b\u4e4b,\u57ce\u6238\u8f1d\u4ec1,\u5bae\u5ddd\u6b63\u7537,\u671b\u6708\u8f1d\u4e00. Dynamic myocardial CT perfusion \u306b\u304a\u3051\u308bMBV \u306e\u865a\u8840\u6027\u5fc3\u75be\u60a3\u306b\u5bfe\u3059\u308b\u6709\u7528\u6027\u306b\u3064\u3044\u3066. \u305b\u3068\u3046\u3061\u5fc3\u81d3CT\u2022MR\u52c9\u5f37\u4f1a.(2018. 10,\u5ca1\u5c71)<br \/>\n19. \u5c71\u672c\u96c4\u592a\uff0c\u7d30\u5ddd\u6d69\u5e73\uff0c\u5fb3\u6c38\u4f38\u5b50\uff0c\u6850\u5c71\u90c1\u5b50\uff0c\u6e05\u6c34\u8f1d\u5f66\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587\uff0c\u843d\u5408\u4eae\u4e8c\uff0c\u5409\u7530\u529f\uff0c\u9ad8\u7551\u6d69\u4e4b\uff0ePeritoneal lymphomatosis\u3067\u767a\u75c7\u3057\u305f\u30d0\u30fc\u30ad\u30c3\u30c8\u30ea\u30f3\u30d1\u816b\u306e1\u4f8b\uff0e\u7b2c131\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a(2018.12, \u9ad8\u677e)<br \/>\n20. \u5ca9\u91ce\u7965\u5b50,\u5e73\u7530\u96c5\u662d,\u7530\u6751\u5468\u592a,\u6a4b\u672c \u60a0,\u4e2d\u6751\u8aa0\u6cbb,\u8d64\u5b97\u660e\u4e45. \u7d4c\u76ae\u7684\u306abiloma\u30c9\u30ec\u30fc\u30f3\u7d4c\u8def\u3092\u5fdc\u7528\u3057\u3066\u5185\u763b\u5316\u3067\u304d\u305f\u7dcf\u80c6\u7ba1\u65ad\u88c2\u306e1\u4f8b. \u7b2c131\u56de\u65e5\u672c\u653e\u5c04\u7dda\u5b66\u4f1a \u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a(2018,12 \u9999\u5ddd)<br \/>\n21. \u6d66\u5ca1\u5927\u77e5,\u677e\u7530\u6075,\u6d25\u7530 \u5b5d\u6cbb,\u7530\u4e2d\u5b8f\u660e,\u8239\u6728 \u7fd4,\u6d77\u8001\u539f \u308b\u3044,\u671b\u6708 \u8f1d\u4e00. Zollinger-Ellison\u75c7\u5019\u7fa4\u3092\u5448\u3057\u305f\u81b5\u30ac\u30b9\u30c8\u30ea\u30ce\u30fc\u30de\u306e\u4e00\u4f8b. \u7b2c131\u56de\u65e5\u672c\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a(2018.12.\u9999\u5ddd)<br \/>\n22. \u8d8a\u667a\u4ec1\u7f8e,\u5409\u7530\u548c\u6a39,\u7530\u908a\u88d5\u8cb4,\u6851\u539f\u5948\u90fd\u7f8e,\u6cb3\u5185\u5b5d\u7bc4,\u5e73\u4e95\u90a6\u660e,\u677e\u7530\u5353\u4e5f,\u5ddd\u53e3\u76f4\u4eba,\u57ce\u6238\u502b\u4e4b,\u57ce\u6238\u8f1d\u4ec1,\u5009\u7530\u8056,\u5bae\u5ddd\u6b63\u7537,\u671b\u6708\u8f1d\u4e00\uff0e\u80a5\u5927\u578b\u5fc3\u7b4b\u75c7\u3092\u80cc\u666f\u3068\u3057\u305f\u5fc3\u5c16\u90e8\u7624,\u51a0\u52d5\u8108\u5de6\u5ba4\u763b\u304c\u7591\u308f\u308c\u305f\u4e00\u4f8b\uff0e\u7b2c131\u56de\u65e5\u672c\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\u3000(2018.12.\u9999\u5ddd)<br \/>\n23. \u5ca1\u7530\u77e5\u4e45,\u6e21\u90e8\u7b11\u9e97,\u4e09\u597d\u88d5\u7f8e,\u4e95\u4e0a\u7950\u99ac,\u68b6\u539f\u8aa0,\u677e\u7530\u5065,\u83ca\u6c60\u6075\u4e00,\u4ed6.\u5fc3\u819c\u4e2d\u76ae\u816b\u306e\uff11\u4f8b. \u7b2c131\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.(2018.12, \u9999\u5ddd)<br \/>\n24. \u9ad8\u9580\u653f\u5609, \u4e09\u6728\u5747, \u9ad8\u5ca1\u53cb\u7d00\u5b50, \u5e74\u68ee\u4e98, \u4e2d\u9808\u8cc0\u4f73\u592e\u91cc, \u6a2a\u4e95\u656c\u5f18, \u798f\u5c71\u76f4\u7d00, \u68ee\u5343\u5c0b, \u6751\u4e0a\u5fe0\u53f8, \u677e\u6728\u5f18\u91cf, \u77f3\u4e38\u826f\u5e83, \u4e95\u4e0a\u6b66. \u5f53\u9662\u306b\u304a\u3051\u308bPI-RADS2\u30ab\u30c6\u30b4\u30ea\u30fc\u3092\u7528\u3044\u305f\u524d\u7acb\u817a\u764c\u8a3a\u65ad\u80fd\u306e\u691c\u8a0e. \u7b2c131\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a \u4e2d\u56fd\uff65\u56db\u56fd\u5730\u65b9\u4f1a. (2018.12, \u9999\u5ddd)<br \/>\n<a name=\"08\"><\/a><strong><span style=\"color: #336699;\">\u25a0<\/span> \u8b1b\u6f14<\/strong><br \/>\n1. \u7247\u5ca1\u6b63\u660e. \u304c\u3093\u306e\u653e\u5c04\u7dda\u6cbb\u7642\uff1a\u57fa\u790e\u304b\u3089\u6700\u65b0\u306e\u6cbb\u7642\u307e\u3067. \u611b\u5a9b\u770c\u751f\u6daf\u6559\u80b2\u8b1b\u5ea7\uff1a\u5f79\u306b\u7acb\u3064\u304c\u3093\u8b1b\u5ea7(2018,8,\u677e\u5c71)<br \/>\n2. \u7247\u5ca1\u6b63\u660e. \u9032\u6b69\u3057\u7d9a\u3051\u308b\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u3064\u3044\u3066. \u677e\u5c71\u5e02\u533b\u5e2b\u4f1a\u3000\u3044\u304d\u3044\u304d\u5065\u5eb7\u587e(2018.11, \u677e\u5c71)<br \/>\n3. \u795e\ufa11\u535a\u5145.VMAT\u5b9f\u8df5\u306e\u3042\u308c\u3053\u308c.\u611b\u5a9b\u653e\u5c04\u7dda\u6cbb\u7642\u7814\u7a76\u4f1a(2018. 1, \u677e\u5c71)<br \/>\n4. \u795e\ufa11\u535a\u5145. \u6559\u80b2\u30bb\u30df\u30ca\u30fc\u3000\u6d88\u5316\u5668\uff0c\u5a66\u4eba\u79d1\uff0c\u6ccc\u5c3f\u5668\u79d1. \u7b2c131\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a(2018.12, \u9ad8\u677e)<br \/>\n5. \u83ca\u6c60\u6075\u4e00\uff0e\u6700\u8fd1\u4f7f\u3063\u3066\u3044\u308b\u30b7\u30fc\u30af\u30a8\u30f3\u30b9.\u3000\u611b\u5a9bMRI\u7814\u7a76\u4f1a(2018.12, \u677e\u5c71)<br \/>\n6. \u57ce\u6238\u8f1d\u4ec1. \u7b2c31\u56de JCR\u30df\u30c3\u30c9\u30a6\u30a3\u30f3\u30bf\u30fc\u30bb\u30df\u30ca\u30fc\uff08\u798f\u5ca1\u56fd\u969b\u4f1a\u8b70\u5834\uff09\u3000\u6559\u80b2\u8b1b\u6f14\u300c\u5fc3\u81d3CT\u304c\u306a\u304f\u3063\u3061\u3083\u59cb\u307e\u3089\u306a\u3044\u300d(2018.1.\u798f\u5ca1)<br \/>\n7. \u57ce\u6238\u8f1d\u4ec1. 2018 Winter Intervention Conference \u30a4\u30f3\u30bf\u30fc\u30d9\u30f3\u30b7\u30e7\u30f3\u6cbb\u7642\u6226\u7565\u306bCT Perfusion\u3092\u6d3b\u304b\u3059\uff082018.3.\u30cb\u30bb\u30b3\uff09<br \/>\n8. \u57ce\u6238\u8f1d\u4ec1. Beyond Angiography Japan XX\u2162 \u51a0\u52d5\u8108\u306e\u652f\u914d\u9818\u57df\u3068\u5fc3\u7b4b Perfusion (2018.3.\u5927\u962a\uff09<br \/>\n9. \u57ce\u6238\u8f1d\u4ec1. AIMS Cardiac Imaging 2018 \u30de\u30eb\u30c1\u30e2\u30c0\u30ea\u30c6\u30a3\u30fc\u6642\u4ee3\u306e\u5fc3\u7b4b\u865a\u8840\u8a55\u4fa1\u306b\u304a\u3051\u308bMRI\u306e\u5f79\u5272 (2018.5.\u6771\u4eac)<br \/>\n10. \u57ce\u6238\u8f1d\u4ec1.\u7b2c57\u56de\u65e5\u672c\u751f\u4f53\u533b\u5de5\u5b66\u4f1a\u3000 \u753b\u50cf\u89e3\u6790\u306e\u7279\u8a31\u53d6\u5f97\u3092\u76ee\u6307\u3057\u3066\u3000\u30fc\u81e8\u5e8a\u7814\u7a76\u533b\u306e\u7acb\u5834\u304b\u3089\u5b66\u3093\u3060\u3053\u3068\u30fc (2018.6.\u672d\u5e4c)<br \/>\n11. \u57ce\u6238\u8f1d\u4ec1. SAMI 2018 \u5fc3\u81d3\u9818\u57df\u3000FFR CT\u3068Compressed Sensing MRI (2018.7.\u6771\u4eac)<br \/>\n12. \u57ce\u6238\u8f1d\u4ec1.\u7b2c12\u56deSCCT\u7814\u7a76\u4f1a\uff082018.9.\u79cb\u8449\u539f\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30db\u30fc\u30eb\uff09\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff12\u3000\u300eFFR-CT\u3001\u5fc3\u7b4bperfusion\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u3069\u3046\u4f7f\u3044\u5206\u3051\u308b\u304b\u300f\u3000Dynamic CT Perfusion\u306b\u3088\u308b\u5fc3\u7b4b\u865a\u8840\u8a55\u4fa1<br \/>\n13. \u57ce\u6238\u8f1d\u4ec1.\u7b2c54\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a\u3000320\u5217Area Detector CT\u306b\u3088\u308b\u5fc3\u81d3\u753b\u50cf\u8a3a\u65ad\u3000\u301c\u5f62\u614b\u8a55\u4fa1\u304b\u3089\u6a5f\u80fd\u8a55\u4fa1\u3078\u301c\uff082018.10.\u798f\u5ca1\u56fd\u969b\u4f1a\u8b70\u5834\uff09<br \/>\n14. \u57ce\u6238\u8f1d\u4ec1.\u7b2c\uff14\uff10\u56de\u3000\u611b\u5a9b\u5fc3\u81d3\u6838\u533b\u5b66\u8ac7\u8a71\u4f1a\u3000\u3000Dynamic CT Perfusion\u306b\u3088\u308b\u5fc3\u7b4b\u865a\u8840\u8a55\u4fa1\uff082018.10.\u677e\u5c71\uff09<br \/>\n15. \u57ce\u6238\u8f1d\u4ec1.\u611b\u5a9b\u770cCanon CT \u30bb\u30df\u30ca\u30fc(2018.12.15)\u3000 320\u5217Area Detector CT\u306b\u3088\u308b\u5fc3\u81d3\u753b\u50cf\u8a3a\u65ad<br \/>\n\u301c\u5f62\u614b\u8a55\u4fa1\u304b\u3089\u6a5f\u80fd\u8a55\u4fa1\u3078\u301c (2018.12 \u677e\u5c71)<br \/>\n16. \u57ce\u6238\u502b\u4e4b. \u5fc3\u81d3MRI\u306b\u304a\u3051\u308bCompressed sensing\u306e\u81e8\u5e8a\u5fdc\u7528. \u7b2c28\u56de\u65e5\u672c\u5fc3\u8840\u7ba1\u753b\u50cf\u52d5\u614b\u5b66\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0(2018. 1, \u6771\u4eac)<br \/>\n17. \u57ce\u6238\u502b\u4e4b. The Recent Development of Stress Myocardial Perfusion Imaging Using Compressed Sensing Technique. \u7b2c77\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3000(2018. 4, \u6a2a\u6d5c)<br \/>\n18. \u57ce\u6238\u502b\u4e4b. \u5fc3\u81d3MRI\u3092\u81e8\u5e8a\u306b\u6d3b\u304b\u3059. \u7b2c77\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\u3000(2018. 4, \u6a2a\u6d5c)<br \/>\n19. \u57ce\u6238\u502b\u4e4b. CMR\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8: \u4e00\u5e74\u9593\u306e\u9032\u6b69\u3092\u4e38\u3054\u3068\u30ec\u30d3\u30e5\u30fc\u3000Compressed sensing. SCMR Japan WG Seminar 2018(2018. 8, \u6771\u4eac)<br \/>\n20. \u57ce\u6238\u502b\u4e4b. Compressed sensing\u306e\u57fa\u672c\u3068\u5fc3\u81d3MRI\u3078\u306e\u5fdc\u7528. \u7b2c46\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u5927\u4f1a\u6559\u80b2\u8b1b\u6f14(2018. 9, \u91d1\u6ca2)<br \/>\n21. \u57ce\u6238\u502b\u4e4b. 2018\u5e74\u5ea6\u8a3a\u7642\u6539\u5b9a\u3092\u8e0f\u307e\u3048\u305f\u865a\u8840\u8a3a\u65ad\u3000\u300eMRI\u300f. \u7b2c40\u56de\u611b\u5a9b\u5fc3\u81d3\u6838\u533b\u5b66\u8ac7\u8a71\u4f1a(2018. 10, \u611b\u5a9b)<br \/>\n22. \u57ce\u6238\u502b\u4e4b. \u65b0\u6280\u8853\u306e\u81e8\u5e8a\u5fdc\u7528\u3000Compressed sensing\u3000\u5fc3\u81d3. \u7b2c22\u56deMRI\u5b9f\u8df5\u30fb\u5148\u7aef\u8b1b\u5ea7(2018. 12, \u6771\u4eac)<br \/>\n23. \u5009\u7530\u8056. \u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u6587\u732e\u30ec\u30d3\u30e5\u30fc. \u7b2c13\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u7814\u7a76\u4f1a\u30bb\u30df\u30ca\u30fc(2018, 2\u6708, \u5927\u962a)<br \/>\n24. \u5009\u7530\u8056. \u5fc3\u81d3 CT \u3092\u7528\u3044\u305f\u51a0\u52d5\u8108\u75be\u60a3\u306e\u6a5f\u80fd\u8a55\u4fa1\uff0e\u7b2c21\u56de\u685c\u6a4b\u30cf\u30f3\u30ba\u30aa\u30f3\u30bb\u30df\u30ca\u30fc(2018, 3\u6708\uff0c\u5927\u962a)<br \/>\n25. \u5009\u7530\u8056. \u5fc3\u81d3CT\u306e\u5c06\u6765\u5c55\u671b\uff0e\u7b2c 5 \u56de EHIMeCT \u30cf\u30f3\u30ba\u30aa\u30f3(2018, 3\uff0c\u611b\u5a9b)<br \/>\n26. \u5009\u7530\u8056. \u5faa\u74b0\u5668\u9818\u57df\u306b\u304a\u3051\u308b3D \u30d7\u30ea\u30c6\u30a3\u30f3\u30b0\u306e\u81e8\u5e8a\u5fdc\u7528\uff0e\u7b2c 77 \u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc(2018, 4\uff0c\u795e\u5948\u5ddd)<br \/>\n27. \u5009\u7530\u8056. \u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u6587\u732e\u30ec\u30d3\u30e5\u30fc. \u7b2c14\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u7814\u7a76\u4f1a\u30bb\u30df\u30ca\u30fc(2018, 5\u6708, \u5927\u962a)<br \/>\n28. \u5009\u7530\u8056. \u5fc3\u81d3 CT \u3092\u7528\u3044\u305f\u51a0\u52d5\u8108\u75be\u60a3\u306e\u6a5f\u80fd\u8a55\u4fa1\uff0e\u7b2c21\u56de\u685c\u6a4b\u30cf\u30f3\u30ba\u30aa\u30f3\u30bb\u30df\u30ca\u30fc(2018.6,\u5927\u962a)<br \/>\n29. \u5009\u7530\u8056. \u5fc3\u81d3CT\u3092\u7528\u3044\u305f\u51a0\u52d5\u8108\u652f\u914d\u9818\u57df\u306e\u5b9a\u91cf\u8a55\u4fa1\uff0e\u7b2c8\u56de\u95a2\u897f\u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad\u611b\u597d\u4f1a(2018.9\uff0c\u5927\u962a)<br \/>\n30. \u5009\u7530\u8056. \u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u6587\u732e\u30ec\u30d3\u30e5\u30fc. \u7b2c15\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u7814\u7a76\u4f1a\u30bb\u30df\u30ca\u30fc(2018, 10, \u5927\u962a)<br \/>\n31. \u5009\u7530\u8056. CT derived FFR, FFRCT\uff0ePCI Optimization by Physiology And Imaging 2018(2018, 10\uff0c\u5c90\u961c)<br \/>\n32. \u5009\u7530\u8056. \u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u6587\u732e\u30ec\u30d3\u30e5\u30fc. \u7b2c16\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u7814\u7a76\u4f1a\u30bb\u30df\u30ca\u30fc(2018, 12, \u5927\u962a)<br \/>\n33. \u83c5\u539f\u656c\u6587\uff0e\u677e\u4e0b\u6751\u587e\u3000\u521d\u7d1a\u587e\uff0ePET\u30b5\u30de\u30fc\u30bb\u30df\u30ca\u30fc2018 in \u5c71\u53e3\u6e6f\u7530\u6e29\u6cc9 (2018.8, \u5c71\u53e3)<br \/>\n34. \u7530\u4e2d\u5b8f\u660e.\u8840\u7ba1\u640d\u50b7\u306b\u304a\u3051\u308bGore Viabahn\u306e\u9069\u6b63\u4f7f\u7528\u3068Tips&amp;Tricks. \u7b2c32\u56de\u4e2d\u56fd\u56db\u56fdIVR\u7814\u7a76\u4f1a.(2018.10,\u5ca1\u5c71)<br \/>\n35. Yuki Tanabe. The role imaging technique in evaluation of patient before and after myocardial revascularization. PERKUMPULAN SUBSPESIALIS RADIOLOGI INTERVENSIONAL INDONESIA. (2018, 3\uff0c\u30a4\u30f3\u30c9\u30cd\u30b7\u30a2)<br \/>\n36. \u4ec1\u4e95\u7530\u308a\u3061\u3000\u8133\u5185\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u304b\u3089\u307f\u305f\u6f22\u65b9\u85ac\u306e\u52b9\u304d\u65b9\uff0d\u6291\u809d\u6563\u306f\u795e\u7d4c\u4fdd\u8b77\u4f5c\u7528\u304c\u3042\u308b\uff0d \u6771\u6d0b\u533b\u5b66\u4f1a\u5175\u5eab\u770c\u90e8\u4f1a(2018.11,\u5175\u5eab)<br \/>\n37. \u5175\u982d\u670b\u5b50. \u6559\u80b2\u8b1b\u6f148-\u8179\u90e8\u9aa8\u76e42: MR\u3068CT\u3067\u307f\u308b\u80c6\u9053\u30fb\u81b5\u7ba1. \u7b2c46\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a (2018. 9, \u91d1\u6ca2)<br \/>\n38. \u677e\u7530\u3000\u6075. \u300c\u809d\u81d3\u306e\u753b\u50cf\u8a3a\u65ad\u2010\u65e5\u5e38\u81e8\u5e8a\u306b\u95a2\u3059\u308b\u3053\u3068\u304b\u3089\u6700\u65b0\u306e\u7814\u7a76\u306b\u3064\u3044\u3066\u307e\u3067\u2010\u300d\u7b2c20\u56de\u6771\u4e88\u653e\u5c04\u7dda\u79d1\u533b\u4f1a.(2018. 1 \u4eca\u6cbb)<br \/>\n39. \u5bae\u5ddd\u6b63\u7537. \u534a\u5c0e\u4f53SPECT\u88c5\u7f6e\u3092\u7528\u3044\u3066CFR\u3092\u6975\u3081\u308b. FRIENDS Live 2018. (2018.3, \u6771\u4eac)<br \/>\n40. \u5bae\u5ddd\u6b63\u7537. \u7279\u5225\u8b1b\u6f14: \u534a\u5c0e\u4f53\u30ab\u30e1\u30e9\u3092\u7528\u3044\u305f\u5fc3\u7b4b\u8840\u6d41SPECT\u306e\u5b9f\u81e8\u5e8a. \u7b2c51\u56de\u3000\u57fc\u7389\u6838\u533b\u5b66\u7814\u7a76\u4f1a (2018.3, \u5927\u5bae)<br \/>\n41. \u5bae\u5ddd\u6b63\u7537. \u5fc3\u7b4b\u8840\u6d41SPECT\u304b\u3089PCI\u306e\u9069\u5fdc\u3092\u8003\u3048\u308b. \u7b2c25\u56de New Horizon for Cardiology (2018.3, \u6771\u4eac)<br \/>\n42. \u5bae\u5ddd\u6b63\u7537. \u5fc3\u7b4b\u8840\u6d41SPECT\u304b\u3089PCI\u306e\u9069\u5fdc\u3092\u8003\u3048\u308b. \u7b2c23\u56de Beyond Angiography Japan (2018.3, \u5927\u962a)<br \/>\n43. \u5bae\u5ddd\u6b63\u7537. \u7279\u5225\u8b1b\u6f14; \u5fc3\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u753b\u50cf\u8a3a\u65ad\u306b\u3064\u3044\u3066. \u7b2c25\u56de\u6d5c\u677e\u6838\u533b\u5b66\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9 (2018.6, \u6d5c\u677e)<br \/>\n44. \u5bae\u5ddd\u6b63\u7537. \u7279\u5225\u8b1b\u6f14; \u5fc3\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u753b\u50cf\u8a3a\u65ad\u306b\u3064\u3044\u3066. \u7b2c25\u56de\u6d5c\u677e\u6838\u533b\u5b66\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9 (2018.6, \u6d5c\u677e)<br \/>\n45. \u5c71\u672c\u5c1a\u5e78\uff0e\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u670d\u7528\u3068\u52b9\u679c\uff0e\u5cf6\u6839\u770c\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u914d\u5e03\u306b\u95a2\u3059\u308b\u7814\u4fee\u4f1a(2018.1,\u677e\u6c5f)<br \/>\n46. \u5c71\u672c\u5c1a\u5e78\uff0e\u8b1b\u7fa91\u3000\u653e\u5c04\u7dda\u306e\u57fa\u790e\u3068\u4eba\u4f53\u3078\u306e\u5f71\u97ff\uff0e\u8b1b\u7fa92\u3000\u539f\u5b50\u529b\u707d\u5bb3\u7dcf\u8ad6 \u5317\u6d77\u9053\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u7814\u4fee\u4f1a(2018.1,\u5036\u77e5\u5b89)<br \/>\n47. \u5c71\u672c\u5c1a\u5e78\uff0e\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u306e\u57fa\u790e\u77e5\u8b58\uff0e\u6d5c\u5ca1\u5730\u533a\u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u8b1b\u6f14\u4f1a(2018.1\uff0e\u83ca\u5ddd)<br \/>\n48. \u5c71\u672c\u5c1a\u5e78\uff0e\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u306e\u52d5\u5411\u306b\u3064\u3044\u3066\uff0e\u4f0a\u65b9\u5730\u533a\u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u8b1b\u6f14\u4f1a(2018.1\uff0e\u516b\u5e61\u6d5c)<br \/>\n49. \u5c71\u672c\u5c1a\u5e78\uff0e\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u306e\u52d5\u5411\u306b\u3064\u3044\u3066\uff0e\u5cf6\u6839\u5730\u533a\u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u8b1b\u6f14\u4f1a(2018.2\uff0e\u51fa\u96f2)<br \/>\n50. \u5c71\u672c\u5c1a\u5e78\uff0e\u6c5a\u67d3\u9632\u8b77\u63aa\u7f6e\u53ca\u3073\u9664\u67d3\u51e6\u7f6e\uff0e\u798f\u4e95\u5730\u533a\u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u8b1b\u6f14\u4f1a(2018.3\uff0e\u82e5\u72ed\u9ad8\u6d5c)<br \/>\n51. \u5c71\u672c\u5c1a\u5e78\uff0e\u539f\u5b50\u529b\u707d\u5bb3\u6642\u306b\u304a\u3051\u308b\u9632\u707d\u696d\u52d9\u95a2\u4fc2\u8005\u306e\u305f\u3081\u306e\u9632\u8b77\u88c5\u5099\uff0e\u611b\u5a9b\u770c\u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u4f1a\u8b70(2018.3\uff0e\u677e\u5c71)<br \/>\n52. \u5c71\u672c\u5c1a\u5e78\uff0e\u539f\u5b50\u529b\u707d\u5bb3\u62e0\u70b9\u75c5\u9662\u306e\u6d3b\u52d5\uff0e\u4eac\u90fd\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u691c\u8a0e\u4f1a(2018.3\uff0e\u4eac\u90fd)<br \/>\n53. \u5c71\u672c\u5c1a\u5e78\uff0e\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u306e\u52d5\u5411\uff0e\u5317\u6d77\u9053\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u5354\u8b70\u4f1a(2018.3\uff0e\u672d\u5e4c)<br \/>\n54. \u5c71\u672c\u5c1a\u5e78\uff0e\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u914d\u5e03\u65b9\u6cd5\u3068\u305d\u306e\u5bfe\u5fdc\uff0e\u5317\u6d77\u9053\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u7814\u4fee\u4f1a(2018.5\uff0e\u5036\u77e5\u5b89)<br \/>\n55. \u5c71\u672c\u5c1a\u5e78\uff0e\u8b1b\u7fa91\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u670d\u7528\u3068\u52b9\u679c\uff0e\u8b1b\u7fa92\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u914d\u5e03\u65b9\u6cd5\u3068\u305d\u306e\u5bfe\u5fdc\u798f\u5ca1\u770c\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u914d\u5e03\u306b\u95a2\u3059\u308b\u7814\u4fee\u4f1a(2018.5. \u7cf8\u5cf6)<br \/>\n56. \u5c71\u672c\u5c1a\u5e78\uff0e\u539f\u5b50\u529b\u707d\u5bb3\u6642\u306e\u88c5\u5099\u3068\u9664\u67d3\uff0e\u4eac\u90fd\u5927\u5b66\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u7814\u4fee\u4f1a(2018.6\uff0e\u4eac\u90fd)<br \/>\n57. \u5bae\u5ddd\u6b63\u7537. \u7279\u5225\u8b1b\u6f14; \u5fc3\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u753b\u50cf\u8a3a\u65ad\u306b\u3064\u3044\u3066. \u7b2c25\u56de\u6d5c\u677e\u6838\u533b\u5b66\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9 (2018.6, \u6d5c\u677e)<br \/>\n58. \u5c71\u672c\u5c1a\u5e78\uff0e\u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u7814\u4fee\u306e\u3042\u308a\u65b9\u306b\u3064\u3044\u3066\uff0e\u65e5\u672c\u8d64\u5341\u5b57\u793e\u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u30a2\u30c9\u30d0\u30a4\u30b6\u30fc\u7814\u4fee\u4f1a(2018.7\uff0e\u6771\u4eac)<br \/>\n59. \u5c71\u672c\u5c1a\u5e78\uff0e\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u670d\u7528\u3068\u52b9\u679c,\u4e8b\u524d\u914d\u5e03\u8aac\u660e\u4f1a\u306e\u5b9f\u969b\uff0e\u9ce5\u53d6\u770c\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u7814\u4fee\u4f1a(2018.7\uff0e\u4e95\u624b\u9999\u5948. \u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\u6559\u80b2\u30bb\u30df\u30ca\u30fc\u3000\u653e\u5c04\u7dda\u8a3a\u65ad\u5b66 \u80ba\u6c17\u7ba1\u652f\u30fb\u816b\u760d. \u7b2c131\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff0812, \u9ad8\u677e\uff09<br \/>\n60. \u5c71\u672c\u5c1a\u5e78\uff0e\u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u306b\u304a\u3051\u308b\u5bfe\u5fdc\u306b\u3064\u3044\u3066\uff0e\u5927\u9593\u75c5\u9662\u8b1b\u6f14\u4f1a(2018.7\uff0e\u5927\u9593)<br \/>\n61. \u5c71\u672c\u5c1a\u5e78\uff0e\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u7dca\u6025\u914d\u5e03\u306e\u6d41\u308c\uff0e\u798f\u4e95\u770c\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u7814\u4fee\u4f1a(2018.8\uff0e\u6771\u821e\u9db4)<br \/>\n62. \u5c71\u672c\u5c1a\u5e78\uff0e\u653e\u5c04\u7dda\u306e\u304a\u306f\u306a\u3057\uff0e\u611b\u5a9b\u770c\u8eab\u306e\u56de\u308a\u306e\u653e\u5c04\u7dda\u6e2c\u5b9a\u4f53\u9a13\u6559\u5ba4(2018.8\uff0e\u677e\u5c71)<br \/>\n63. \u5c71\u672c\u5c1a\u5e78\uff0e\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u306e\u52d5\u5411\uff0e\u77f3\u5ddd\u770c\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u4f1a\u8b70(2018.9\uff0e\u91d1\u6ca2)<br \/>\n64. \u5c71\u672c\u5c1a\u5e78\uff0e\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u306b\u95a2\u3059\u308b\u56fd\u306e\u52d5\u5411\u306b\u3064\u3044\u3066\uff0e\u65b0\u6f5f\u770c\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u4f1a\u8b70(2018.9\uff0e\u65b0\u6f5f)<br \/>\n65. \u5c71\u672c\u5c1a\u5e78\uff0e\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u306b\u95a2\u3059\u308b\u7dcf\u8ad6\uff0e\u5317\u6d77\u9053\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u7814\u4fee\u4f1a(\u907f\u96e3\u9000\u57df\u6642\u691c\u67fb)(2018.10\uff0e\u672d\u5e4c)<br \/>\n66. \u5c71\u672c\u5c1a\u5e78\uff0e\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u5354\u529b\u6a5f\u95a2\u7814\u4fee(2018.10,\u5927\u6d32)<br \/>\n67. \u5c71\u672c\u5c1a\u5e78\uff0e\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u914d\u5e03\u306e\u6d41\u308c\u3000\u6551\u8b77\u6240\u306b\u304a\u3051\u308b\u5bfe\u5fdc\u306b\u3064\u3044\u3066\uff0e\u5bcc\u5c71\u770c\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u7814\u4fee\u4f1a(2018.11,\u9ad8\u5ca1)<br \/>\n68. \u5c71\u672c\u5c1a\u5e78\uff0e\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u306b\u3064\u3044\u3066\uff0e\u4eac\u90fd\u5e9c\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u7814\u4fee\u4f1a(2018.11,\u7dbe\u90e8)<br \/>\n69. \u5c71\u672c\u5c1a\u5e78\uff0e\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u914d\u5e03\u306e\u6d41\u308c\u3000\u6551\u8b77\u6240\u306b\u304a\u3051\u308b\u5bfe\u5fdc\u306b\u3064\u3044\u3066\uff0e\u5bcc\u5c71\u770c\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u7814\u4fee\u4f1a(2018.11,\u9ad8\u5ca1)<br \/>\n70. \u5c71\u672c\u5c1a\u5e78\uff0e\u30b5\u30a4\u30c8\u306b\u304a\u3051\u308b\u521d\u671f\u88ab\u3070\u304f\u533b\u7642\uff0e\u5ddd\u5185\u5730\u533a\u8b1b\u6f14\u4f1a\u5b9f\u52d9\u30bb\u30df\u30ca\u30fc(2018.12,\u5ddd\u5185)<br \/>\n71. \u5c71\u672c\u5c1a\u5e78\uff0e\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u306e\u52d5\u5411\u306b\u3064\u3044\u3066\uff0e\u516d\u30b1\u6240\u5730\u533a\u8b1b\u6f14\u4f1a\u5b9f\u52d9\u30bb\u30df\u30ca\u30fc(2018.12,\u5341\u548c\u7530)<br \/>\n72. \u5c71\u672c\u5c1a\u5e78\uff0e\u9577\u8c37\u5ddd\u6709\u53f2\u3000\u673a\u4e0a\u6f14\u7fd2\u300c\u6c5a\u67d3\u304c\u6b8b\u5b58\u3057\u305f\u5834\u5408\u306e\u5bfe\u5fdc\u3068\u5185\u90e8\u6c5a\u67d3\u304c\u7591\u308f\u308c\u308b\u5834\u5408\u306e\u5bfe\u5fdc\u300d\u65b0\u6f5f\u770c\u707d\u5bb3\u533b\u7642\u30b3\u30fc\u30c7\u30a3\u30cd\u30fc\u30bf\u7814\u4fee\u4f1a(2018.12,\u65b0\u6f5f)<br \/>\n73. \u4e95\u624b\u9999\u5948. \u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\u6559\u80b2\u30bb\u30df\u30ca\u30fc\u3000\u653e\u5c04\u7dda\u8a3a\u65ad\u5b66 \u80ba\u6c17\u7ba1\u652f\u30fb\u816b\u760d. \u7b2c131\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff0812, \u9ad8\u677e\uff09<br \/>\n74. \u6cb3\u5185\u7fa9\u5f18\uff0c\u4e95\u624b\u9999\u5948\uff0c\u671b\u6708\u8f1d\u4e00.\u3000\u4eba\u9593\u30c9\u30c3\u30af\u306b\u3066\u767a\u898b\u3055\u308c\u305f\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u306e\u4e00\u4f8b\uff0e\u7b2c\uff12\u56de\u4e2d\u56fd\u56db\u56fd\u80f8\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff08\uff11\uff10\u6708\uff0c\u5ca1\u5c71\uff09<br \/>\n<a name=\"09\"><\/a><strong><span style=\"color: #336699;\">\u25a0<\/span> \u7814\u7a76\u52a9\u6210<\/strong><br \/>\n1. \u5bae\u5ddd\u6b63\u7537. \u65e5\u672c\u5b66\u8853\u632f\u8208\u4f1a \u79d1\u7814\u8cbb \u57fa\u76e4\u7814\u7a76(C) \u5fc3\u623f\u7d30\u52d5\u306e\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u3068\u3057\u3066\u306ePET\u304a\u3088\u3073\u534a\u5c0e\u4f53SPECT\u306e\u6709\u7528\u6027\u306e\u691c\u8a0e (H29\u5e74\uff5eH31\u5e74\u3000\u7814\u7a76\u4ee3\u8868\u8005)<br \/>\n<a name=\"10\"><\/a><strong><span style=\"color: #336699;\">\u25a0<\/span>\u00a0\u305d\u306e\u4ed6<\/strong><br \/>\n\uff11. \u5bae\u5ddd\u6b63\u7537.\u3000\u611b\u5a9b\u5927\u5b66\u7279\u4efb\u6559\u6388\u306e\u79f0\u53f7\u4ed8\u4e0e2018\u5e742\u67081\u65e5\u4ed8<br \/>\n\uff12. \u6cb3\u5185\u5b5d\u7bc4. \u56a2\u80de\u6027\u5b50\u5bae\u817a\u7b4b\u816b\u75c7\u306e\u4e00\u4f8b. \u7b2c20\u56de\u677e\u5c71\u653e\u5c04\u7dda\u79d1\u533b\u4f1a. (2018.6 \u611b\u5a9b)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2018\u5e74\u696d\u7e3e\u3000\u305d\u306e2 \u25a0\u3000\u5b66\u4f1a\u30fb\u7814\u7a76\u4f1a\u767a\u8868 \u56fd\u5185\u5b66\u4f1a\uff08\u5168\u56fd\uff09 \u56fd\u5185\u5b66\u4f1a\uff08\u5730\u65b9\u4f1a\uff09 \u25a0 \u8b1b\u6f14 \u25a0 \u7814\u7a76\u52a9\u6210 \u25a0 \u53d7\u8cde \u8ad6\u6587\u3001\u56fd\u969b\u5b66\u4f1a\u767a\u8868\u306f2018\u5e74\u696d\u7e3e\u3000\u305d\u306e1\u3092\u3054\u89a7\u4e0b\u3055\u3044\u3002 &nbsp; \u25a0 \u5b66\u4f1a\u767a\u8868(\u56fd\u5185) \u25cf \u56fd\u5185 [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[20],"tags":[],"class_list":["post-5089","post","type-post","status-publish","format-standard","hentry","category-20"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/posts\/5089","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/comments?post=5089"}],"version-history":[{"count":0,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/posts\/5089\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/media?parent=5089"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/categories?post=5089"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/tags?post=5089"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}